Skip to main content

Table 2 Risk of bias assessment of included RCTs

From: Dexmedetomidine in prevention and treatment of postoperative and intensive care unit delirium: a systematic review and meta-analysis

  1. aPatient blinded
  2. bBlocked randomization in unblinded trial
  3. cPatients with delayed recovery were excluded
  4. dStudy reported as double blind; it is likely that patients and personnel were blinded, but this is unclear for the outcome assessor
  5. eStudy reported as double blind, but blinding of patients is not explicitly mentioned
  6. fNo flow chart provided; unclear if more patients were originally included